Sanofi Pasteur, a Sanofi Company $SNY
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS9
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO44%
Delay Index: of 9 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +4.4 months). See all sponsors →
Open Sanofi Pasteur, a Sanofi Company on the live radar map → 📅 $SNY readout calendar (.ics)| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Yellow fever vaccine (produced on serum-free Vero cells) NCT05011123 |
P2 | Active, not recruiting | Yellow Fever | 690 | 2022-05-23 (+4 mo) |
| VYF02 NCT04942210 |
P2 | Active, not recruiting | Yellow Fever; Healthy Volunteers | 568 | 2022-06-24 (+7 mo) |
| Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine NCT04936685 |
P3 | Active, not recruiting | Meningococcal Immunisation; Healthy Volunteers | 209 | 2023-03-09 (+4 mo) |
| PCV21 NCT06838000 |
P3 | Active, not recruiting | Pneumococcal Infections | 1268 | 2026-12-01 (+6 mo) |
| Investigational hMPV/RSV vaccine NCT06686654 |
P1/2 | Active, not recruiting | Human Metapneumovirus Immunization; Respiratory Syncytial Virus Immunization | 1530 | 2027-01-18 (-6 mo) |
| Pentavalent Meningococcal ABCYW vaccine NCT06647407 |
P1/2 | Active, not recruiting | Meningococcal Immunization; Healthy Volunteers | 750 | 2027-05-17 |
| PCV21 vaccine NCT06736041 |
P3 | Active, not recruiting | Pneumococcal Immunization | 1714 | 2027-05-17 |
| Acne mRNA vaccine NCT06316297 |
P1/2 | Recruiting | Acne | 800 | 2028-11-30 (+11 mo) |
| Acne mRNA vaccine NCT07013747 |
P1/2 | Recruiting | Acne | 228 | 2029-06-19 (+33 mo) |